Lexaria Bioscience Corp (LEXX)
2.35
+0.16
(+7.31%)
USD |
NASDAQ |
Apr 26, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Shareholders Equity (Quarterly): 6.521M for Feb. 29, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 6.521M |
November 30, 2023 | 3.742M |
August 31, 2023 | 3.044M |
May 31, 2023 | 4.396M |
February 28, 2023 | 4.974M |
November 30, 2022 | 6.262M |
August 31, 2022 | 7.949M |
May 31, 2022 | 9.184M |
February 28, 2022 | 11.46M |
November 30, 2021 | 11.68M |
August 31, 2021 | 13.27M |
May 31, 2021 | 10.34M |
February 28, 2021 | 11.77M |
November 30, 2020 | 1.878M |
August 31, 2020 | 2.525M |
May 31, 2020 | 3.187M |
February 29, 2020 | 1.880M |
November 30, 2019 | 2.526M |
August 31, 2019 | 2.383M |
May 31, 2019 | 3.179M |
February 28, 2019 | 2.779M |
November 30, 2018 | 3.414M |
August 31, 2018 | 2.388M |
May 31, 2018 | 2.637M |
February 28, 2018 | 2.772M |
Date | Value |
---|---|
November 30, 2017 | 2.402M |
August 31, 2017 | 3.006M |
May 31, 2017 | 3.265M |
February 28, 2017 | 0.6912M |
November 30, 2016 | 0.8067M |
August 31, 2016 | 0.266M |
May 31, 2016 | 0.1207M |
February 29, 2016 | 0.265M |
November 30, 2015 | 0.4638M |
August 31, 2015 | 0.7724M |
May 31, 2015 | 1.152M |
February 28, 2015 | 1.145M |
November 30, 2014 | 1.416M |
July 31, 2014 | 3.550M |
April 30, 2014 | 3.732M |
January 31, 2014 | 2.027M |
October 31, 2013 | 2.099M |
July 31, 2013 | 2.225M |
April 30, 2013 | 2.262M |
January 31, 2013 | 2.309M |
October 31, 2012 | 2.421M |
July 31, 2012 | 2.388M |
April 30, 2012 | 2.320M |
January 31, 2012 | 2.552M |
October 31, 2011 | 2.661M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.878M
Minimum
Nov 2020
13.27M
Maximum
Aug 2021
6.107M
Average
4.685M
Median
Shareholders Equity (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 377.95M |
Sunshine Biopharma Inc | 21.21M |
Acasti Pharma Inc | 64.68M |
Edesa Biotech Inc | 5.845M |
Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.352M |
Total Liabilities (Quarterly) | 0.2042M |
Current Ratio | 66.29 |